Skip to main content
UHSUniversal Health Services, Inc.Sell5.8·$170.02-0.70%
SellModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5xStable
  • Strong Earnings Beat With Analyst UpsideImproving
  • Confirmed Downtrend Death Cross BlockImproving
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Recovery setup

SellValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $170.02 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$170.02+2.7% A.UpsideScore 5.8/10#11 of 33 Medical Care Facilities
QualityF-score8 / 9FCF yield4.97%
IncomeYield0.47%(5y avg 0.51%)Payout3.27%sustainable
Stop $158.12Target $174.55(analyst − 10%)A.R:R 0.2:1
Analyst target$193.94+14.1%17 analysts
$174.55our TP
$170.02price
$193.94mean
$290

Sell if holding. Analyst target reached at $170.02 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2). Chart setup: Death cross but MACD improving, RSI 63. Score 5.8/10, moderate confidence.

Passes 4/8 gates (clean insider activity, earnings proximity 71d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Oct 26, 202671d to earnings· next earnings call

Thesis

Rewards
Attractive valuation
Margin of safety: 54%
Risks
Analyst target reached - limited upside remaining
Consecutive earnings misses (2)
Below 200-MA, MA slope -3.1%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)6.9
P/E (Fwd)7.0
Mkt Cap$10.0B
EV/EBITDA5.7
Profit Mgn8.4%
ROE20.9%
Rev Growth8.3%
Beta1.06
Dividend0.47%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.02bullish
IV52%elevated
Max Pain$210+23.5% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
2.1
Bollinger
3.4
52w Position
3.8
GatesMomentum 4.1<4.5A.R:R 0.2 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentInsider activity: OKEARNINGS PROXIMITY 71d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
63 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $147.07Resistance $176.03

Price Targets

$158
$175
A.Upside+2.7%
A.R:R0.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (2.7% upside)
! NEWS_MOD=-1: HOLD_IF_HOLDING → SELL_IF_HOLDING
! momentum at 4.1 (below the engine's 4.5 threshold)

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-10-26 (71d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Sell if holding. Analyst target reached at $170.02 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2). Chart setup: Death cross but MACD improving, RSI 63. Prior stop was $158.12. Score 5.8/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $174.55 (+2.7% upside). Prior stop was $158.12. Stop-loss: $158.12.

What are the risks of investing in UHS?

Analyst target reached - limited upside remaining; Consecutive earnings misses (2); Below 200-MA, MA slope -3.1%/30d (confirmed downtrend).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 6.9 (forward 7.0). TrendMatrix value score: 7.9/10. Verdict: Sell.

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.4/5. Average price target: $194.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CON (Concentra Group Holdings Parent) · THC (Tenet Healthcare Corporation) · LFST (LifeStance Health Group, Inc.)
Home Stocks UHS

Latest news

Latest News

Yahoo Finance25d agoEarnings
GuruFocus25d ago
Yahoo Finance116d ago
Yahoo Finance116d agoEarnings
TradingKey60d ago
AD HOC NEWS60d agoAnalyst
Sahm67d ago
Marketscreener.com26d ago
TipRanks26d ago
The Globe and Mail117d agoEarnings
TradingView117d agoEarnings
AD HOC NEWS61d agoEarnings
AD HOC NEWS61d ago
GuruFocus33d ago
Yahoo Finance33d ago
Smartkarma33d ago
Quiver Quantitative33d ago
Yahoo Finance68d ago
Newsline.com69d agoEarnings
TradingView24d agoEarnings
Loading more...